Washington Examiner
Sign in Subscribe
News
Politics
Trump Administration
White House
Senate
House
Campaigns
Business
World
Investigations
Justice
Supreme Court
Crime
Entertainment
Washington Secrets
Policy
Defense
National Security
Energy and Environment
Education
Immigration
Finance and Economy
Healthcare
Foreign Policy
Tech
Infrastructure
Space
2026 Election
Trump Administration
IN FOCUS
Commentary
Columnists
Editorials
Think Tanks
Beltway Confidential
Op-Eds
Restoring America
Patriotism and Unity
Faith, Freedom, and Self-Reliance
Courage, Strength, and Optimism
Equality, Not Elitism
Community and Family
Fairness and Justice
Mission
Watch
Magazine
Magazine
Quarterly Briefing
Archives
Games
Sponsored
Powering Progress
ASAE – Association Leadership
National Parks
Examining Tax Reform
Fix TSCA
Inside the Corn Belt
Newsletters
Sign In Home
News
Politics Business World Investigations Justice Supreme Court Crime Entertainment Washington Secrets
Policy 2026 Election
Opinion
Columnists Editorials Think Tanks Beltway Confidential Op-Eds Editorial Cartoons
In Focus Restoring America Magazine Watch
Sponsored
Special Sections Advertise
TWS Archive
Advertisement
Advertisement
Home › Tags › Posts tagged Pfizer

Tag: Pfizer

"We're hearing the beginning of a giant sucking sound," said Rep. Kevin Brady. "Many more companies could be forced to restructure." (AP File Photo/J. Scott Applewhite) Economy

Fleeing firms put pressure on Congress and candidates

Joseph Lawler · February 26, 2016 5:01 am
"Pfizer and other pharmaceutical companies can no longer be allowed to rip off American patients who already pay the highest prices in the world for prescription drugs," Bernie Sanders said. (AP Photo) Business

Sanders seizes on report that Pfizer will dodge $35 billion in taxes

Joseph Lawler · February 25, 2016 7:21 pm
Ohio and California aren't the only states to consider taking action on drug prices, but their effort goes the furthest. (Frank Polich/Bloomberg News) Healthcare

Drug companies spend millions to fight price cap laws

Robert King · December 29, 2015 5:01 am
Sanders typically leads the 2016 democratic candidates in leaning to the left on issues. While Sanders took the most stringent view of the merger, other candidates echoed the democratic socialist's view. (AP Photo/Carolyn Kaster) Politics

Sanders leads leftward Dem movement on Pfizer merger

Ariel Cohen · November 23, 2015 10:37 pm
Pfizer executives donated $39,375 directly to Clinton's presidential campaign between April and the end of September, according to Federal Election Commission records. (AP Photo/Charlie Neibergall) Healthcare

Clinton blasts Pfizer, a major Clinton donor

Sarah Bedford · November 23, 2015 8:55 pm
Blighted property lies June 27, 2005 in downtown New London, Connecticut. Today, the land that was once the Fort Trumbull neighborhood of New London, Conn., is a field of rubble. The brilliant plans of the powerful planners failed. They had torn down a neighborhood to make it nicer for a new Pfizer plant. Pfizer left the plant a few years later. Nothing has taken the place of Fort Trumbull. (Photo by Spencer Platt/Getty Images) Business

Property rights are for the little guy: Raisins and Kelo at 10 years

Timothy P. Carney · June 23, 2015 9:03 pm
Of the 55 firms that donated to the foundation, 36 paid to lobby the State Department during at least one year of Clinton’s term. (AP)

Most firms that gave to Clinton Foundation also lobbied State Department

Sarah Bedford · May 15, 2015 9:00 am
Pfizer to pay $35M to settle drug marketing case Business

Pfizer to pay $35M to settle drug marketing case

Washington Examiner · August 6, 2014 9:07 pm
(iStock Image) Columnists

Why lobbying is a dud for most companies but benefits their CEOs

Timothy P. Carney · July 12, 2014 9:00 pm
Pfizer wins third case over subsidiary’s asbestos-containing product

Pfizer wins third case over subsidiary’s asbestos-containing product

Heather Isringhausen Gvillo · June 26, 2014 2:59 pm
Third Circuit dismisses securities class action lawsuit against Pfizer Healthcare

Third Circuit dismisses securities class action lawsuit against Pfizer

Kyla Asbury · June 23, 2014 7:32 pm
In this May 4, 2014 photo, the Pfizer logo is displayed on the exterior of a former Pfizer factory  in the Brooklyn borough of New York. Pfizer says it does not intend to make a takeover offer for British drugmaker AstraZeneca. The Monday, May 26, 2014 announcement comes a week after AstraZeneca's board rejected a proposed $119 billion buyout offer from Pfizer, the world's second-biggest drugmaker by revenue. (AP Photo/Mark Lennihan, File) Business

Pfizer pulls plug on push to buy AstraZeneca

Alex Veiga · May 26, 2014 6:29 pm
Advertisement
300 x 250
Advertisement
  • ‹Previous page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • ›Next page
Page 28 of 30
Advertisement
Advertisement
Washington Examiner Manage Preferences

News

  • Politics
    • White House
    • Senate
    • House
    • Campaigns
  • Business
  • World
  • Investigations
  • Justice
  • Supreme Court
  • Crime
  • Washington Secrets
  • Entertainment
  • Sports

Policy

  • Defense
  • National Security
  • Energy
  • Immigration
  • Finance and Economy
  • Healthcare
  • Foreign Policy
  • Tech
  • Infrastructure
  • Space

Commentary

  • Columnists
  • Editorials
  • Think Tanks
  • Beltway Confidential
  • Op-Eds

Restoring America

  • Patriotism & Unity
  • Faith, Freedom & Self-Reliance
  • Courage, Strength & Optimism
  • Equality, Not Elitism
  • Community & Family
  • Fairness & Justice
  • Mission

Watch

  • Latest Videos
  • Political Perspectives
  • Restoring America Show
  • The Debrief
  • Reporter’s Notebook
  • Games
NEWSLETTERS MAGAZINE ARCHIVE
  • Policies and Standards
  • Terms Of Service
  • Subscription Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Transparency In Coverage
  • Advertise
  • Subscribe
  • Contact
  • Careers
  • Staff
  • About Examiner
  • Facebook
  • Twitter
© Copyright 2026. Washington Examiner. All Rights Reserved.
Advertisement